Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
27.32
-0.21 (-0.74%)
Feb 24, 2025, 10:08 AM EST - Market open
Apellis Pharmaceuticals Revenue by Segment
History
| Date | Product | Collaboration License and Other |
|---|---|---|
| Sep 30, 2024 | 657.44M | 57.78M |
| Jun 30, 2024 | 580.05M | 48.74M |
| Mar 31, 2024 | 490.56M | 33.51M |
| Dec 31, 2023 | 366.28M | 30.31M |
| Sep 30, 2023 | 247.28M | 25.60M |
| Jun 30, 2023 | 165.77M | 18.76M |
| Mar 31, 2023 | 91.78M | 14.10M |
| Dec 31, 2022 | 65.09M | 10.33M |
| Sep 30, 2022 | 54.65M | 58.40M |
| Jun 30, 2022 | 42.29M | 54.36M |
| Mar 31, 2022 | 27.26M | 53.69M |
| Dec 31, 2021 | 15.15M | 51.42M |
| Sep 30, 2021 | 5.94M | 250.34M |
| Jun 30, 2021 | 623.00K | - |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.